302
Participants
Start Date
January 31, 2014
Primary Completion Date
July 31, 2015
Study Completion Date
August 31, 2015
N-Acetylcysteine
Study participants randomly assigned to the NAC arm will receive a 12-week course of N-Acetylcysteine (1200mg) twice daily. All participants will concurrently participate in weekly medication management sessions and twice-weekly contingency management interventions.
Placebo
Study participants randomly assigned to the placebo arm will receive a matched placebo twice daily. All participants will concurrently participate in weekly medication management sessions and twice-weekly contingency management interventions.
Behavioral Health Services of Pickens County, Pickens
University of Kentucky, Lexington
University of Texas Health Science Center at San Antonio, San Antonio
UCLA Integrated Substance Abuse Programs, Los Angeles
CODA, Inc., Portland
APT Foundation, Inc., New Haven
National Institute on Drug Abuse (NIDA)
NIH
Medical University of South Carolina
OTHER